These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Urogenital infections linked to Chlamydia and mycoplasmas]. Fourmaux S; Bebear C Prog Urol; 1997 Feb; 7(1):132-6. PubMed ID: 9116732 [TBL] [Abstract][Full Text] [Related]
25. Prevalence and treatment of Chlamydia trachomatis, Ureaplasma urealyticum, and Mycoplasma hominis in patients with non-gonococcal urethritis. Kilic D; Basar MM; Kaygusuz S; Yilmaz E; Basar H; Batislam E Jpn J Infect Dis; 2004 Feb; 57(1):17-20. PubMed ID: 14985631 [TBL] [Abstract][Full Text] [Related]
26. [Female urogenital mycoplasma infection and drug sensitivity status in Changsha]. Zuo CX; Huang JH; Chen J; Lu JY; Xiang YP Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):831-2, 836. PubMed ID: 16793613 [TBL] [Abstract][Full Text] [Related]
32. [Mycoplasma infections of urogenital tract]. Hofstetter A Hautarzt; 1977 Jun; 28(6):295-8. PubMed ID: 885718 [TBL] [Abstract][Full Text] [Related]
33. Comparative in vitro susceptibilities and bactericidal activities of investigational fluoroquinolone ABT-492 and other antimicrobial agents against human mycoplasmas and ureaplasmas. Waites KB; Crabb DM; Duffy LB Antimicrob Agents Chemother; 2003 Dec; 47(12):3973-5. PubMed ID: 14638513 [TBL] [Abstract][Full Text] [Related]
34. [In vitro activity of Septivon-Lavril toward mycoplasma pathogenic to humans]. Bonissol C; Kona P Pathol Biol (Paris); 1985 Oct; 33(8):843-6. PubMed ID: 3903624 [TBL] [Abstract][Full Text] [Related]
35. The killing of Ureaplasma urealyticum and Mycoplasma hominis by povidone-iodine. Furr PM; Taylor-Robinson D J Antimicrob Chemother; 1980 Mar; 6(2):225-30. PubMed ID: 7380768 [No Abstract] [Full Text] [Related]
36. [Incidence of Mycoplasma hominis and Ureaplasma urealyticum in pregnant women and gynecologic patients and their treatment with doxycycline]. Horváth B; Turay A; Lakatos F; Végh G; Illei G Orv Hetil; 1987 May; 128(19):979-82. PubMed ID: 3587970 [No Abstract] [Full Text] [Related]
37. [Value of the antibiogram for the treatment of urogenital Ureaplasma infections]. Bonissol C; Daoulas-Lebourdelles F Pathol Biol (Paris); 1978 Dec; 26(9-10):539-46. PubMed ID: 34136 [TBL] [Abstract][Full Text] [Related]
38. Ureaplasma urealyticum and Mycoplasma hominis infection in women with urogenital diseases. Zdrodowska-Stefanow B; Kłosowska WM; Ostaszewska-Puchalska I; Bułhak-Kozioł V; Kotowicz B Adv Med Sci; 2006; 51():250-3. PubMed ID: 17357319 [TBL] [Abstract][Full Text] [Related]
39. Prevalence of Ureaplasma urealyticum and Mycoplasma hominis in women with chronic urinary symptoms. Baka S; Kouskouni E; Antonopoulou S; Sioutis D; Papakonstantinou M; Hassiakos D; Logothetis E; Liapis A Urology; 2009 Jul; 74(1):62-6. PubMed ID: 19371925 [TBL] [Abstract][Full Text] [Related]
40. Comparative in vitro activities of investigational peptide deformylase inhibitor NVP LBM-415 and other agents against human mycoplasmas and ureaplasmas. Waites KB; Reddy NB; Crabb DM; Duffy LB Antimicrob Agents Chemother; 2005 Jun; 49(6):2541-2. PubMed ID: 15917568 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]